Published in J Geriatr Cardiol on June 01, 2012
Long-term results of single-procedure catheter ablation for atrial fibrillationin pre- and post-menopausal women. J Geriatr Cardiol (2014) 0.79
Brazilian contribution to a better understanding of geriatric cardiology. J Geriatr Cardiol (2012) 0.75
Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med (1998) 23.22
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA (2001) 16.98
A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med (2002) 16.31
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med (2009) 11.49
Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med (2007) 10.87
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest (2010) 10.29
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation (2004) 8.80
Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med (2009) 8.51
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med (1992) 8.38
Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med (1999) 7.74
Obesity and the risk of new-onset atrial fibrillation. JAMA (2004) 6.73
KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science (2003) 6.60
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace (2010) 6.31
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med (2007) 5.78
Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med (1997) 5.25
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol (2011) 5.06
Identification of a genetic locus for familial atrial fibrillation. N Engl J Med (1997) 4.66
Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA (2003) 4.13
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol (1994) 4.08
Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation (2004) 4.04
An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med (1996) 3.86
Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol (2004) 3.50
Atrial fibrillation. N Engl J Med (2001) 3.00
Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke (1997) 2.79
Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators. Ann Intern Med (1992) 2.67
Antithrombotic therapy in atrial fibrillation. Chest (2001) 2.62
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol (2011) 2.48
Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi. Ann Intern Med (1998) 2.22
Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. Eur Heart J (2008) 2.09
Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. J Am Coll Cardiol (2007) 1.76
Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. Arch Intern Med (2008) 1.68
Dronedarone for prevention of atrial fibrillation: a dose-ranging study. Eur Heart J (2003) 1.63
Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial. Eur Heart J (2004) 1.58
Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards. Eur J Intern Med (2010) 1.47
Association of the human minK gene 38G allele with atrial fibrillation: evidence of possible genetic control on the pathogenesis of atrial fibrillation. Am Heart J (2002) 1.43
Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J (2001) 1.33
Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis. Arch Intern Med (2005) 1.24
From delirium cordis to atrial fibrillation: historical development of a disease concept. Ann Intern Med (1995) 1.19
The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation (1993) 1.16
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. Europace (2011) 1.14
Left atrial transport function in myocardial infarction. Importance of its booster pump function. Am J Med (1975) 1.14
Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide. Circulation (2003) 1.10
Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort. Eur Heart J (2007) 1.10
Left anterior descending coronary artery wall thickness measured by high-frequency transthoracic and epicardial echocardiography includes adventitia. Am J Cardiol (2003) 1.10
Assessment of cardiac function in patients who were morbidly obese. Surgery (1990) 1.07
Annual incidence of atrial fibrillation and related factors in adults. Am J Cardiol (2010) 1.02
Thyrotoxicosis in institutionalized elderly patients with atrial fibrillation. Arch Intern Med (1984) 0.90
Thromboembolism in chronic atrial flutter: is the risk underestimated? J Am Coll Cardiol (1997) 0.90
The genetics of atrial fibrillation. Curr Opin Cardiol (2010) 0.87
Persistent atrial fibrillation: current approach and controversies. Curr Opin Cardiol (2010) 0.83
New approaches to atrial fibrillation management: treat the patient, not the ECG. Cardiovasc Ther (2010) 0.81
Risks and benefits of rate control versus maintenance of sinus rhythm. Am J Cardiol (2003) 0.81
Left atrial transport function. Trans Am Clin Climatol Assoc (1981) 0.76
New pharmacotherapy for stroke prevention in atrial fibrillation: update 2010. Adv Ther (2010) 0.76
Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillation. Curr Opin Cardiol (2010) 0.76
[II Guidelines of Brazilian Society of Cardiology in geriatric cardiology]. Arq Bras Cardiol (2010) 0.83
[Off-pump myocardial revascularization in the elderly: analysis of morbidity and mortality]. Rev Bras Cir Cardiovasc (2008) 0.76